Previous 10 | Next 10 |
JERUSALEM , March 16, 2021 (GLOBE NEWSWIRE) -- Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that it has filed its annual report on Form 10-K for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission. ...
Gainers: Sigma Labs (SGLB) +162%.Check-Cap (CHEK) +110%.Rubius Therapeutics (RUBY) +69%.Luokung Technology (LKCO) +43%.Shaw Communications (SJR) +38%.RumbleON (RMBL) +38%.Aeterna Zentaris (AEZS) +31%.Baosheng Media (BAOS) +30%.Intec Pharma (NTEC) +29%.GenMark Diagnostics (GNMK)...
5 Names For Your Penny Stocks List We’re kick-starting another week where penny stocks are at the center of attention. While economic data could fuel broader markets, sentiment and momentum seem to be carrying things forward for small-cap stocks. Premarket trading in benchmark ET...
Intec Pharma (NTEC) surges 87% premarket after entering into a merger agreement with privately-held Decoy Biosystems.The combined company will advance its immunotherapy platform to battle a variety of tumor types and chronic viral infections.Upon completion of the merger, the former...
Intec Pharma Ltd (NTEC) +142% on announcing merger agreement with Decoy Biosystems.Check-Cap Ltd. (CHEK) +113% after receiving FDA IDE approval for pivotal study of C-Scan®.Acer Therapeutics (ACER) +67%.Shaw Communications (SJR) +55% as Rogers to acquire the company in C$2...
Intec Pharma and Decoy Biosystems Announce Merger Agreement Combined Company to Advance Novel Immunotherapy Technology that Primes Both Innate and Adaptive Immune Responses, Targeting Multiple Tumor Types and Chronic Viral infections Investigational New Drug Application Fili...
Penny Stocks Heating Up Scanners This Week As New Trends Take Hold There’s no denying that 2021 has been a banner year already, and we’re only about a month in. So far, we’ve seen certain penny stocks break out thousands of percentage points. We’ve also s...
The cannabis sector is poised for great growth due to potential for more permissive regulations. US MSOs are better situated to gain from new regulations than their Canadian counterparts. An actively managed ETF play can be a good solution to avoid specific stocks in a turbulent s...
Oncternal Therapeutics (ONCT) -25% on increasing previously announced bought deal offer to $75.0M.GeoVax Labs (GOVX) -23%.Xenetic Biosciences (XBIO) -21%. on launching $6M registered direct offering priced at-the-market.Savara (SVRA) -19% on providing pipeline and business...
Gainers: Greenwich LifeSciences (GLSI) +424%.Xenetic Biosciences (XBIO) +329%.Rocket Pharmaceuticals (RCKT) +79%.MTS Systems (MTSC) +52%.Cypress Environmental Partners (CELP) +46%.Intec Pharma (NTEC) +42%.ZW Data Action Technologies (CNET) +33%.Cardtronics (CATM) +33%.Editas Medicine (ED...
News, Short Squeeze, Breakout and More Instantly...
Intec Pharma Ltd. Company Name:
NTEC Stock Symbol:
NASDAQ Market:
- Chief Scientific Officer Dr. Newman to present initial clinical data that further validates Company’s “Pulse-Prime” hypothesis - Dr. Newman also named Chair of the Summit NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a...
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that its Chief Medical Officer, Roger Waltzman, M.D., will present an update on ...
Latest data from first and second cohorts support Company’s 'pulse-prime' approach, demonstrating rapid clearance, broad immune activation, and encouraging safety profile Poster Presented at American Society of Clinical Oncology Annual Meeting NEW YORK, June 03, 2024 (GLOBE...